Healthcare / Diagnostics & ResearchUpdated 2026-05-10 22:07 UTC

NEO stock hub

NeoGenomics, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NEOis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.2B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

NEO

In the news

Latest news · NEO

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E37.3

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-11.6

P25 -105.6P50 -46.5P75 -3.1

ROIC-5.7

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NEO market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

237

Groups with data

Currency

USD

Showing 237 of 237 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001077183
Company name	NeoGenomics, Inc.
Country	United States
Country code	US
Cusip	64049M209
Employees	2,500
Employees Change	300%
Employees Change Percent	13.64
Enterprise value	$1.4B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Diagnostics & Research
IPO Date	1999-11-02
Isin	US64049M2098
Last refreshed	2026-05-10
Market cap	$1.2B
Market cap category	Small-Cap
Price	$8.96
Price currency	USD
Rev Per Employee	298,387.6x
Sector	Healthcare
Sic	8734
Symbol	NEO
Website	https://www.neogenomics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-8.5%
EV Sales Forward	1.73x
EV/EBITDA	334.92x
EV/Sales	1.92x
FCF yield	-0.44%
Forward P/E	37.35x
P/B ratio	1.4x
P/S ratio	1.56x
PEG ratio	0.72x
PS Forward	1.41x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-8.34%
EBITDA Margin	0.57%
Gross margin	43.1%
Gross Profit	$321.5M
Gross Profit Growth	7.93%
Gross Profit Growth Q	10.4%
Gross Profit Growth3 Y	16.28%
Gross Profit Growth5 Y	11.52%
Net Income	$-99.2M
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Pretax Margin	-13.7%
Profit Margin	-13.3%
Profit Per Employee	$-39,683
ROA	-2.64
Roa5y	-3.92
ROCE	-4.93
ROE	-11.56
Roe5y	-8.93
ROIC	-5.72
Roic5y	-9.38

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	1%
Cagr15y	12.91%
Cagr1y	12.01%
Cagr20y	14.47%
Cagr3y	-16.35%
Cagr5y	-26.26%
EPS Growth Quarters	2
EPS Growth Years	0
OCF Growth	194.57%
OCF Growth10 Y	4.64%
OCF Growth5 Y	16.16%
Revenue Growth	10.95x
Revenue Growth Q	11.09x
Revenue Growth Quarters	17x
Revenue Growth Years	24x
Revenue Growth3 Y	12.08x
Revenue Growth5 Y	10.44x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.51
Assets	$1.3B
Cash	$146.1M
Current Assets	$373.7M
Current Liabilities	$84.6M
Debt	$408.5M
Debt EBITDA	$30.78
Debt Equity	$0.49
Equity	$828.8M
Interest Coverage	-22.77
Liabilities	$517.8M
Long Term Assets	$972.8M
Long Term Liabilities	$433.2M
Net Cash	$-262.4M
Net Cash By Market Cap	$-22.49
Net Debt EBITDA	$61.49
Net Debt Equity	$0.32
Tangible Book Value	$25.9M
Tangible Book Value Per Share	$0.2
WACC	10.63

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.42
Inventory Turnover	14.24
Net Working Capital	$147.8M
Quick ratio	3.71
Working Capital	$289.1M
Working Capital Turnover	$2.56

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.24%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	10.48%
1Y total return	12%
200-day SMA	9.48
3Y total return	-41.48%
50-day SMA	8.4
50-day SMA vs 200-day SMA	50under200
5Y total return	-78.19%
All Time High	61.57
All Time High Change	-85.45%
All Time High Date	2021-02-16
All Time Low	0.04
All Time Low Change	22,300%
All Time Low Date	2003-04-16
ATR	0.54
Beta	1.8
Beta1y	1.69
Beta2y	1.15
Ch YTD	-23.81
High	9.03
High52	13.74
High52 Date	2026-01-12
High52ch	-34.79%
Low	8.68
Low52	4.72
Low52 Date	2025-08-01
Low52ch	89.83%
Ma50ch	6.73%
Premarket Change Percent	0.28
Premarket Price	$9.1
Premarket Volume	57,018
Price vs 200-day SMA	-5.48%
RSI	55.23
RSI Monthly	44.7
RSI Weekly	45.82
Sharpe ratio	0.42x
Sortino ratio	0.73
Total Return	-1.24%
Tr YTD	-23.81
Tr15y	517.93%
Tr1m	11.17%
Tr1w	-5.08%
Tr3m	-21.54%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	8
Analyst Count Top	1
Analyst Price Target Top	$13
Analyst Ratings	Strong Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.02
Earnings Revenue Estimate	184,470,584x
Earnings Revenue Estimate Growth	9.78x
Operating Income	$-62.2M
Operating margin	-8.34
Price target	$13.38
Price Target Change	$49.33
Price Target Change Top	$45.09

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	118,894,953%
Float Percent	91.31%
Net Borrowing	-201,250,000
Shares Insiders	1.95%
Shares Institutions	107.33%
Shares Out	130,211,780
Shares Qo Q	0.4%
Shares Yo Y	1.24%
Short Float	6.63%
Short Ratio	4.97
Short Shares	6.05

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-45.3M
Average Volume	2,740,063x
Bv Per Share	6.39
CAPEX	$-27.5M
Ch10y	10.48
Ch15y	517.9
Ch1m	11.17
Ch1w	-5.08
Ch1y	12
Ch20y	1,393.3
Ch3m	-21.54
Ch3y	-41.48
Ch5y	-78.19
Ch6m	-11.11
Change	-1.21%
Change From Open	-0.78
Close	9.07
Days Gap	-0.44
Depreciation Amortization	66,509,000
Dollar Volume	15,661,184
Earnings Date	2026-04-28
Earnings Time	amc
EBIT	$-62.2M
EBITDA	$4.3M
EPS	$-0.77
F Score	4
FCF	$-5.1M
FCF EV Yield	-0.36x
FCF Per Share	$-0.04
Financing CF	-201,575,000
Fiscal Year End	December
Founded	2,001
Goodwill	523,995,000
Income Tax	$-3M
Investing CF	-20,896,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-04-28
Last Report Date	2026-03-31
Last Split Date	2003-04-16
Last Split Type	Reverse
Last10k Filing Date	2026-02-17
Ma150	10.28
Ma150ch	-12.87%
Ma20	8.61
Ma20ch	4.08%
Net CF	-200,051,000
Next Earnings Date	2026-07-28
Open	9.03
Optionable	Yes
P OCF Ratio	52.04
Position In Range	80
Post Close	8.96
Postmarket Change Percent	0.45
Postmarket Price	$9
Ppne	160,362,000
Pre Close	9.07
Price Date	2026-05-08
Price EBITDA	$273
Ptbv Ratio	45.1
Relative Volume	0.64x
Revenue	745,969,000x
SBC By Revenue	5.39x
Share Based Comp	40,198,000
Tax By Revenue	-0.4x
Tr20y	1,393.33%
Tr6m	-11.11%
Us State	Florida
Volume	1,747,900
Z Score	1.55

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does NEO pay a dividend?

Capital-return profile for this ticker.

Performance

NEO stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NEO?

Insider, institutional, and short-interest positioning.

Institutional ownership

+107.3%

Float: +91.3% of shares outstanding

Insider ownership

+2.0%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

NEO momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

55.2

Neutral momentum band

Price vs 200-day MA

-5.5%

50/200-day relationship not available

Beta (5Y)

1.80

More volatile than the market

Sharpe ratio

0.42

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NEO

Hub-level FAQ points readers to the deeper analysis pages.

What is the current NEO stock rating?

NeoGenomics, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full NEO analysis?

The full report lives at /stocks/NEO/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for NEO?

The latest report frames NEO around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the NEO page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.